For the Inventor, By the Inventor

Enter inventor name

Lafayette, CA, United States of America

Roberto L Ceriani

USPTO Granted Patents = 17

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 248(Granted Patents)

Location History:

Walnut Creek, CA (US) (2005)
Lafayette, CA (US) (1986 - 2008)

Company Filing History:

Cancer Research Fund of Contra Costa

John Muir Cancer & Aging Institute

Cancer Research Institute of Contra Costa

Cancer Research Fund

5. 1 out of 413

Cincinnati Children's Hospital Medical Center

Ibc Pharmaceuticals, Inc.

7. 2 out of 832,891

Other

patents

Years Active: 1986-2008

Loading Chart...

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE40535 - Anti-KC4 humanized monoclonal antibody and cells that express the antibody (2008-10-06),

2. 6939677 - Antibody with 46 kdalton HMFG antigen binding specificity, immunoassay kit and diagnostic method (2005-09-06),

3. 6936706 - Modified antibodies with human milk fat globule specificity and uses (2005-08-30),

4. 6315997 - Use of modified antibodies with human milk fat globule specificity (2001-11-13),

5. 6309636 - Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides (2001-10-30),

6. 6190885 - Fusion protein containing HMFG Epitop E (S) (2001-02-20),

7. 5804187 - Modified antibodies with human milk fat globule specificity (1998-09-08),

8. 5792852 - Polynucleotides encoding modified antibodies with human milk fat globule (1998-08-11),

9. 5766571 - Method of treating human breast cancer by administration of radiolabeled (1998-06-16),

10. 5536647 - Nucleic acids and vector encoding HMFQ polypeptide, transfected host, (1996-07-16),

11. 5532135 - Solid-phase competitive assay utilizing a fusion protein (1996-07-02),

12. 5514558 - Highly sensitive and specific solid-phase competitive assay utilizing a (1996-05-07),

13. 5455031 - Polypeptide with 46 Kdalton HMFG differentiation antigen binding (1995-10-03),

14. 5077220 - Monoclonal antibody specific to a novel glycoprotein antigen on human (1991-12-31),

15. 5075219 - Monoclonal antibody which recognizes a specific glycoprotein of a human (1991-12-24),

Title: The Innovative Journey of Roberto L Ceriani

Introduction: Roberto L Ceriani, a distinguished inventor hailing from Lafayette, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Roberto L Ceriani's latest patents showcase his ingenuity and forward-thinking approach to innovation, with a focus on cutting-edge technologies in the digital realm.

Career Highlights: Throughout his illustrious career, Roberto L Ceriani has consistently pushed the boundaries of what is possible, earning a reputation as a visionary in the tech industry. His innovative spirit and dedication to excellence have led to the creation of numerous groundbreaking inventions.

Collaborations: Roberto L Ceriani has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly with teams of experts has been instrumental in the success of his projects.

Conclusion: In conclusion, Roberto L Ceriani stands as a shining example of an inventor whose passion for innovation knows no bounds. His remarkable contributions to the world of technology continue to inspire and shape the future of the industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…